BG
Bellevue Group Portfolio holdings
AUM
$4.81B
1-Year Est. Return
29.28%
1 Year Est. Return
+29.28%
AUM
$4.54B
AUM Growth
+$74.3M
(+1.7%)
Holding
155
Top Buys
| 1 | +$39.2M | |
| 2 | +$38.3M | |
| 3 | +$36.5M | |
| 4 |
Thermo Fisher Scientific
TMO
|
+$20M |
| 5 |
Edgewise Therapeutics
EWTX
|
+$17.7M |
Top Sells
| 1 | +$35.5M | |
| 2 | +$29.9M | |
| 3 | +$25.6M | |
| 4 |
Boston Scientific
BSX
|
+$20M |
| 5 |
Cencora
COR
|
+$19M |
Sector Composition
| 1 | Healthcare | 99.88% |
| 2 | Technology | 0.01% |
| 3 | Consumer Discretionary | 0.01% |
| 4 | Communication Services | 0.01% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
NeoGenomics
NEO
$1.34B
| $6.67M | 0.15% |
913,082
-303,674
|
|
||
|
WAY
77
Waystar Holding Corp
WAY
$6.76B
| $6.16M | 0.14% |
150,610
+6,184
|
|
||
78
Axsome Therapeutics
AXSM
$7.04B
| $5.87M | 0.13% |
56,253
-40,154
|
|
||
79
Glaukos
GKOS
$5.17B
| $5.78M | 0.13% |
55,926
|
|
||
80
Gilead Sciences
GILD
$155B
| $5.7M | 0.13% |
51,416
-3,606
|
|
||
81
IQVIA
IQV
$37.6B
| $5.31M | 0.12% |
33,700
-27,368
|
|
||
82
Ascendis Pharma
ASND
$12.5B
| $4.95M | 0.11% |
28,655
+26,755
|
|
||
83
Baxter International
BAX
$9.49B
| $4.61M | 0.1% |
152,291
-304,155
|
|
||
|
OMDA
84
Omada Health Inc
OMDA
$1.16B
| $4.58M | 0.1% |
+250,000
|
|
||
85
BrightSpring Health Services
BTSG
$5.77B
| $4.52M | 0.1% |
191,706
-50,043
|
|
||
86
10x Genomics
TXG
$2.01B
| $3.78M | 0.08% |
326,751
+95,754
|
|
||
87
BioNTech
BNTX
$24.8B
| $3.73M | 0.08% |
35,039
+27,075
|
|
||
88
Cardinal Health
CAH
$48.8B
| $3.36M | 0.07% |
20,012
-764
|
|
||
89
Legend Biotech
LEGN
$5.59B
| $3.03M | 0.07% |
85,438
-5,753
|
|
||
90
AstraZeneca
AZN
$276B
| $2.68M | 0.06% |
38,400
-1,600
|
|
||
91
Illumina
ILMN
$18.4B
| $2.64M | 0.06% |
27,624
|
|
||
|
92
Cencora
COR
$70.2B
| $2.39M | 0.05% |
7,970
-63,390
|
|
||
93
Merck
MRK
$231B
| $2.24M | 0.05% |
28,239
-203,132
|
|
||
|
KMTS
94
Kestra Medical Technologies
KMTS
$1.29B
| $2.22M | 0.05% |
133,761
|
|
||
95
CVS Health
CVS
$98.8B
| $2.08M | 0.05% |
30,096
-1,659
|
|
||
96
SPDR S&P 500 ETF Trust
SPY
$667B
| $1.92M | 0.04% |
3,100
-2,560
|
|
||
97
Bristol-Myers Squibb
BMY
$95B
| $1.72M | 0.04% |
37,177
+11,611
|
|
||
98
Pfizer
PFE
$142B
| $1.72M | 0.04% |
70,915
-49,831
|
|
||
|
VRNA
99
DELISTED
Verona Pharma
VRNA
| $1.51M | 0.03% |
15,927
-45,334
|
|
||
100
Doximity
DOCS
$9.34B
| $1.46M | 0.03% |
23,816
|
|